InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: Curt D post# 25701

Thursday, 10/08/2020 6:19:03 PM

Thursday, October 08, 2020 6:19:03 PM

Post# of 44690
The cost for a course Ipillmumab/Navolumab is $450K for initial dose combo and $7K twice a month for just the lesser maintenance doses of Optivo. Medicine is Expen$ive and requires great insurance or ridiculous out of pocket. BUT, it's better than death. BUT2, customers have to be able to pay for it. Now what abouth ETHICS as Dr. JJ points out.?.

I think we could do better here with a target price for Aviptadil (IV) much less than is talked about. After manufacturing and logistics what is a reasonable price?
I read that India has a knockoff of Rem pretty cheap.

I hope the prototype Inhaler ,when seen, will be planned for MASS use, Cheap. $20-$50 a few dose unit? Selling a couple hundred Million of those (yearly?) is a better bet than targeting High-end Rich. This all needs to get thru trials, against Big P with their own obvious current support...GLTA...